MedPath

The influence of Curcumin on Non-alcoholic fatty liver disease

Phase 2
Conditions
onalcoholic fatty liver disease.
Fatty (change of) liver, not elsewhere classified
Registration Number
IRCT2017012031423N1
Lead Sponsor
Vice Chancellor for research of Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

1. having ALT and AST upper than highest normal level
2. have at least one of the following:
A) Diabetes
B) Hyperlipidemia
C) Obesity
3. The age of 15 to 60
Exclusion criteria:
1. Alcohol consumption
2. Get a positive serology of viral hepatitis
3. ANA or AMA positive test, Alpha1 Antitrypsin, Low serum levels of Seroloplasin or high levels of antibodies of ASMA or LKM.
4. High ferritin 450 or Iron/TIBC> 45%
5. The patient before the intervention or during the intervention, affected with acute or chronic disease that causes in LFT disorders.
6.The patient before the intervention or during the intervention is consuming medicine that potentially capable of Disrupting the LFT.
7. Pregnancy
8. Patients Younger than 15 or older than 60.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath